Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
ANAPTYSBIO, INC market cap for the quarter ending 2026-05-07 was $1.95B, a 347.16% increase year-over-year.
ANAPTYSBIO, INC market cap for the quarter ending 2026-04-23 was $1.49B, a 243.15% increase year-over-year.
ANAPTYSBIO, INC market cap for the quarter ending 2026-03-31 was $1.61B, a 328.21% increase year-over-year.
ANAPTYSBIO, INC market cap for the quarter ending 2026-02-27 was $1.58B, a 349.07% increase year-over-year.
ANAPTYSBIO, INC market cap for fiscal 2026 was $1.95B.
ANAPTYSBIO, INC market cap for fiscal 2025 was $1.36B, a 405.12% increase from fiscal 2024.
ANAPTYSBIO, INC market cap for fiscal 2024 was $268.98M, a 29.18% decline from fiscal 2023.
ANAPTYSBIO, INC market cap for fiscal 2023 was $379.81M, a 35.53% decline from fiscal 2022.